0G8X

Noticias Immunovia Ab (publ)

Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Immunovia Ab (publ) 0G8X London Acción Ordinaria
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.0% 191.40 18:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
191.40
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
30/11/202202:09PRNUSCenters for Medicare & Medicaid Services finalizes its..
30/11/202202:07PRNUSCenters for Medicare & Medicaid Services finalizes its..
16/11/202201:47PRNUSChief Executive Offier, Philipp Mathieu, buys Immunovia..
16/11/202201:46PRNUSChief Executive Offier, Philipp Mathieu, buys Immunovia..
11/11/202210:58PRNUSImmunovia announces the financial calendar for financial..
11/11/202210:56PRNUSImmunovia announces the financial calendar for financial..
10/11/202201:57PRNUSImmunovia Publishes Interim Report Jan-Sep 2022
10/11/202201:56PRNUSImmunovia Publishes Interim Report Jan-Sep 2022
03/11/202208:25PRNUSInvitation to Immunovia's Q3 presentation
03/11/202208:24PRNUSInvitation to Immunovia's Q3 presentation
20/10/202202:15PRNUSNomination Committee appointed for the 2023 Annual General..
20/10/202202:13PRNUSNomination Committee appointed for the 2023 Annual General..
19/10/202202:05PRNUSImmunovia announces executive management team changes to..
19/10/202202:03PRNUSImmunovia announces executive management team changes to..
17/10/202201:47PRNUSImmunovia launches a strategic partnership with Proteomedix..
17/10/202201:44PRNUSImmunovia launches a strategic partnership with Proteomedix..
12/10/202201:41PRNUSImmunovia announces positive update on physician experience..
12/10/202201:39PRNUSImmunovia announces positive update on physician experience..
26/9/202202:05PRNUSCenters for Medicare & Medicaid Services issues preliminary..
26/9/202202:03PRNUSCenters for Medicare & Medicaid Services issues preliminary..
24/8/202201:47PRNUSImmunovia Publishes Interim Report Jan-June 2022
24/8/202201:45PRNUSImmunovia Publishes Interim Report Jan-June 2022
23/8/202201:52PRNUSImmunovia to present at Gilmartin Group's Emerging Growth..
23/8/202201:49PRNUSImmunovia to present at Gilmartin Group's Emerging Growth..
22/8/202206:41PRNUSInvitation to Immunovia's Q2 presentation
22/8/202206:40PRNUSInvitation to Immunovia's Q2 presentation
11/8/202203:53PRNUSImmunovia, Inc. Issued Clinical and Public Health Laboratory..
11/8/202203:49PRNUSImmunovia, Inc. Issued Clinical and Public Health Laboratory..
05/7/202202:47PRNUSImmunovia: CPT PLA Code for the IMMray™ PanCan-d test..
05/7/202202:45PRNUSImmunovia: CPT PLA Code for the IMMray™ PanCan-d test..
30/6/202202:31PRNUSThe PanDIA-1 study, for early detection of pancreatic cancer..
30/6/202202:24PRNUSThe PanDIA-1 study, for early detection of pancreatic cancer..
27/6/202202:25PRNUSInvitation to Immunovia's Presentation of PanFAM-1 Results
27/6/202202:19PRNUSInvitation to Immunovia's Presentation of PanFAM-1 Results
27/6/202202:07PRNUSPanFAM-1 Results Partly Inconclusive
27/6/202201:55PRNUSPanFAM-1 Results Partly Inconclusive
02/6/202201:47PRNUSPhilipp Mathieu appointed CEO of Immunovia AB
02/6/202201:46PRNUSPhilipp Mathieu appointed CEO of Immunovia AB
23/5/202202:01PRNUSImmunovia, Inc. market access increases when achieving..
23/5/202201:57PRNUSImmunovia, Inc. market access increases when achieving..
17/5/202201:48PRNUSImmunovia, Inc. achieves Clinical Laboratory Licensure from..
17/5/202201:46PRNUSImmunovia, Inc. achieves Clinical Laboratory Licensure from..
16/5/202201:49PRNUSImmunovia strengthens its US team through the appointment of..
16/5/202201:46PRNUSImmunovia strengthens its US team through the appointment of..
28/4/202201:40PRNUSImmunovia Publishes Interim Report January-March 2022
28/4/202201:35PRNUSImmunovia Publishes Interim Report January-March 2022
21/4/202203:44PRNUSInvitation to Immunovia's Q1 presentation
21/4/202203:43PRNUSInvitation to Immunovia's Q1 presentation
14/4/202202:12PRNUSImmunovia CPT PLA Code submission for the IMMray™ PanCan-d..
14/4/202202:11PRNUSImmunovia CPT PLA Code submission for the IMMray™ PanCan-d..
Su Consulta Reciente
LSE
0G8X
Immunovia ..
Regístrese ahora para ver estas acciones en su Monitor streaming ADVFN.

Usted puede agregar y ver hasta 110 símbolos de sus acciones favoritas al mismo tiempo y completamente gratis.

Inicie sesión en ADVFN
Regístrase ahora

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

P: V: D:20221202 14:23:53